Doctor Thyroid

This is an in depth discussion about the connection between flame retardants and plastics, and thyroid cancer. These chemicals, also known as endocrine disruptors, have a clear connection to thyroid cancer occurrence. The research is presented by Julie Ann Sosa, MD MA FACS is Chief of Endocrine Surgery at Duke University and leader of the endocrine neoplasia diseases group in the Duke Cancer Institute and the Duke Clinical Research Institute. She is Professor of Surgery and Medicine. Her clinical interest is in endocrine surgery, with a focus in thyroid cancer. She is widely published in outcomes analysis, as well as cost-effectiveness analysis, meta-analysis, and survey-based research, and she is director of health services research. NOTES: Study Associates Flame Retardants with Papillary Thyroid Cancer Flame retardants used in furniture may increase thyroid cancer risk Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 How to Buy a Sofa without Toxic Flame Retardants Julie Ann Sosa, MD

I sometimes get asked, why am I doing this podcast? What started out as a pet project is now being listened to in over 30 countries and with as many as 20000 downloads per episode. So far, thyroid patients are embracing the opportunity to hear from the world's leading thyroid doctors, and gaining the information needed to make better decisions related to health. So why did I start Doctor Thyroid? My motivation for doing this podcast is to help patients avoid bad experiences related to thyroid cancer and thyroid disease, including bad surgery. And, provide resources to help make better health decisions and improve quality of life. My thyroid surgery resulted in errors, which have downgraded my quality of life significantly. Knowing what I know now, I would have picked a different surgeon, or chosen no surgery at all. Because, as this interview will discuss, although perceived as safe, thyroid surgery is not without risks. To be published next month, new research reveals thyroid surgery errors are five times more likely than previously reported. The study was conducted by Dr. Maria Papaleontiou. She is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes. She graduated medical school from the prestigious Charles University in the Czech Republic and subsequently spent several years conducting research at the Geriatrics Division at Weill Cornell Medical College. She then completed her internal medicine residency at Saint Peter's University Hospital in New Jersey and her endocrinology fellowship at the University of Michigan. She joined the faculty at the University of Michigan in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Dr. Papaleontiou's practice focuses on thyroid disorders and thyroid cancer. She is especially interested in the treatment of endocrine disorders in older adults. She also conducts health services research in the field of thyroidology and aging. NOTES Dr. Maria Papaleontiou Complications from thyroid cancer surgery more common than believed, study finds National Cancer Institute (NCI) RELATED DOCTOR THYROID INTERVIEWS Dr. Ralph Tufano: Be Careful, Not All Surgeons Are Equal and Here is Why Dr. Gary Clayman: The Single Most Important Question to Ask Your Surgeon Dr. Allen Ho: Rethinking Thyroid Cancer – When Saying No to Surgery Maybe Best for You

Dr. Rashika Bansal is a PGY-2 resident in Internal Medicine at St. Joseph's Regional Medical Center in Paterson, NJ. Her major research has been with diabetes prevalence and awareness in rural India, with special interest in thyroid disease. In this episode Dr. Bansal shares the research she presented at AACE 2017 and ENDO 2017, regarding the poor readability scores for thyroid cancer web sites. The challenge for these web sites and health institutions is to translate thyroid education from complex to simple and easy to understand. Currently, many patients are not following with treatment, citing confusion after being exposed to the various thyroid cancer education resources. NOTES Thyroid Education Scores Low for Readability Thyroid patient education materials not adequately targeted to patient reading level

Weighing treatment options for thyroid cancer, with deep consideration for the patient's lifestyle, could become the new norm in assessing whether surgery is the best path. Dr. Allen Ho states, "if a patient is a ballerina or an opera singer, or any other profession that could be jeopardized due to undesired consequences of thyroid cancer surgery, then the best treatment path maybe active surveillance." Undesired consequences of thyroid cancer surgery could be vocal cord paralysis, damage to the parathyroid glands resulting in calcium deficiencies, excessive bleeding or formation of a major blood clot in the neck, shoulder nerve damage, numbness, wound infection, and mental impairment due to hypothyroid-like symptoms. Or in the case of a ballerina, undesired scarring could jeopardize a career. The above risks occur in approximately 10% of thyroid cancer surgeries. Although, some thyroid cancer treatment centers have a much more reduced incidence of undesired consequences, while others much higher. In order to address the above and remove the risk of thyroid cancer surgery, Cedars-Sinai has become the first west coast hospital to launch an active surveillance study as optional treatment for thyroid cancer. The study includes 200 patients from across the country who have chosen the wait and see approach rather than hurry into a surgery that could result in undesired, major life changes. By waiting, this means these patients will dodge the need to take daily hormone replacement medication for the rest of their lives as the result of a thyroidectomy. Other active surveillance research Although this is the first study for active surveillance on the west coast, other studies are ongoing, including Sloan Kettering as directed by Dr. Tuttle, Kuma Hospital in Kobe as directed by Dr. Miyauchi, and the Dartmouth Institute as directed by Dr. Louise Davies. The team Dr. Ho says the "de-escalating" of treatment for thyroid cancer will become the new trend. The active surveillance thyroid cancer team at Cedars-Sinai is orchestrated to the patient's needs, and includes the pathologist, endocrinologist, and surgeon. About Dr. Allen Ho Allen Ho, MD, is a fellowship-trained head and neck surgeon who focuses on head and neck tumors, including HPV(+) throat cancers and thyroid malignancies. As director of the Head and Neck Cancer Program and co-director of the Thyroid Cancer Program, he leads the multidisciplinary Cedars-Sinai Head and Neck Tumor Board, which provides consensus management options for complex, advanced cases. Ho's research interests are highly integrated into his clinical practice. His current efforts lie in cancer proteomics, HPV(+) oropharyngeal cancer pathogenesis, and thyroid cancer molecular assays. He has presented his research at AACR, ASCO, AHNS, and ATA, and has published extensively as lead author in journals that include Nature Genetics, Journal of Clinical Oncology, Cancer, and Thyroid. Ho serves on national committees within the ATA and AHNS, and is principal investigator of a national trial on micropapillary thyroid cancer active surveillance (ClinicalTrials.gov ID: NCT02609685). He maintains expertise in transoral robotic surgery (TORS), minimally invasive thyroidectomy approaches, and nerve preservation techniques. Ho's overarching mission is to partner with patients to optimize treatment and provide compassionate, exceptional care. NOTES American Thyroid Association Cedars-Sinai clinical trial MSKCC thyroid cancer active surveillance THYCA Support Group Active Surveillance of Thyroid Cancer Under Study

What Happens When Thyroid Cancer Travels to the Lungs? Fabian Pitoia, M.D., serves as the Head of the Thyroid Section of the Division of Endocrinology and Investigation Area Coordinator at the Hospital de Clinicas of the University of Buenos Aires (UBA). He works also as an Proffessor of internal medicine at the Faculty of Medicine (UBA). Dr Pitoia serves as a Full Member of the Argentine Society of Endocrinology and Metabolism, of the Latin American Thyroid Society, the Endocrine Society and he is a Correspondent Member of the American Thyroid Association. In this episode Dr. Pitoia addresses the following topics: 10% of thyroid cancer patients will have distant metastatic disease The disease will travel to lungs, bones, or both Treatment with RAI is most effective for those under 40 years old Evaluation of metastatic thyroid cancer in the lungs is a CT scan In 2006, there was a change in the treatment of the disease Adverse events of medication The coordination between the endocrinologist and the oncologist RESOURCES ResearchGate Dr. Pitoia - Facebook Dr. Pitoia - web site Dr. Pitoia - Twitter Thyroid Cancer Alliance American Thyroid Association Hospital de Clínicas de la Universidad de Buenos Aires - Ciudad Autónoma de Buenos Aires. Consultorio privado: Pte. J.E. Uriburu 754 - Piso 2. Teléfonos: 49545488/49525496 [email protected]

Bienvenido al episodio 33 de Doctor Thyroid con Philip James. El invitado de hoy es Dr. Fabian Pitoia. El Dr. Pitoia es un experto endocrino mundial, que aparece en muchas publicaciones y conferencias mundiales, donde habla de cáncer de tiroides. El Dr Pitoia es médico endocrinólogo, está encargado de la Sección Tiroides de la División Endocrinología del Hospital de Clínicas de la Universidad de Buenos Aires. En este episodio, el Dr. Pitoia responde las siguientes preguntas: ¿Qué es la enfermedad metastásica en relación con el cáncer de tiroides? Hay una tendencia de este enfermedad? ¿cómo se descubre la enfermedad metastásica? cuando se trata de cáncer de tiroides es un procedimiento típico para los médicos para detectar la enfermedad metastásica? si un paciente no responde a RAI (radioactiva), ¿qué es una opción de tratamiento? ¿Podemos hacer vigilancia activa cuando hay metástasis en los pulmones, ¿es lo mismo que el cáncer de pulmón? 600 milicurios de RAI .... ¿Hay peligro para este alto de una dosis? ¿hay efectos secundarios o peligros a los medicamentos usados ​​para tratar la enfermedad metastásica que no responde a la radiación? se le informa a un paciente de la enfermedad metastásica, y este es un área de estrés para los pacientes con cáncer de tiroides, ¿puede decirle a un paciente algo para reducir la ansiedad relacionada con la enfermedad metastásica? si un paciente tiene enfermedad metastásica, ¿es necesario un médico especial para el tratamiento? ¿cómo sabemos si un médico se especializa en la enfermedad metastásica? ¿hay una página web o recursos adicionales para aprender más sobre la enfermedad metastásica? Recursos: Dr. Pitoia - Facebook Dr. Pitoia - pagina web Dr. Pitoia - Twitter ResearchGate Thyroid Cancer Alliance American Thyroid Association - Español Hospital de Clínicas de la Universidad de Buenos Aires - Ciudad Autónoma de Buenos Aires. Consultorio privado: Pte. J.E. Uriburu 754 - Piso 2. Teléfonos: 49545488/49525496 [email protected]

El término nódulo tiroideo se refiere a cualquier crecimiento anormal de las células tiroideas formando un tumor dentro de la tiroides. Aunque la gran mayoría de los nódulos tiroideos son benignos (no cancerosos), una pequeña proporción de estos nódulos sí contienen cáncer de tiroides. Es por esta posibilidad que la evaluación de un nódulo tiroideo está dirigida a descubrir un potencial cáncer de tiroides. En esta entrevista, el Dr. Castro explica los siguientes temas: ¿Qué es un nódulo tiroideo? ¿Cuáles son los síntomas de un nódulo tiroideo? ¿Cómo se diagnostica el nódulo tiroideo? Punción de la tiroides con aguja fina Ecografía de la tiroides ¿Cómo se tratan los nódulos de la tiroides? Cuando la observación activa es la opción de tratamiento en lugar de una tiroidectomía Niños con nódulos tiroideos M. Regina Castro, MD es consultante en la División de Endocrinología de la Clínica Mayo de Rochester, MN. Es Profesora Asociada de Medicina. Es Directora Asociada del Programa de entrenamiento en la especialidad de Endocrinología, y Directora de la rotación de Endocrinología para la Residencia de Medicina Interna. También es miembro del Grupo de Tiroides de la Clínica Mayo. Ella sirvió de 2009 a 2015 como Editor de Sección de la Tiroides para el Programa de Autoevaluación de AACE y ha sido autora de varios capítulos sobre Hipertiroidismo, Nódulos de Tiroides y cáncer Notas Nódulos Tiroideos Regina Castro Publications American Thyroid Association en Español

In this episode Dr. Bernet describes that Hashimoto's thyroiditis is an autoimmune condition that usually progresses slowly and often leads to low thyroid hormone levels — a condition called hypothyroidism. The best therapy for Hashimoto's thyroiditis is to normalize thyroid hormone levels with medication. A balanced diet and other healthy lifestyle choices may help when you have Hashimoto's, but a specific diet alone is unlikely to reverse the changes caused by the disease. Hashimoto's thyroiditis develops when your body's immune system mistakenly attacks your thyroid. It's not clear why this happens. Some research seems to indicate that a virus or bacterium might trigger the immune response. It's possible that a genetic predisposition also may be involved in the development of this autoimmune disorder. A chronic condition that develops over time, Hashimoto's thyroiditis damages the thyroid and eventually can cause hypothyroidism. That means your thyroid no longer produces enough of the hormones it usually makes. If that happens, it can lead to symptoms such as fatigue, sluggishness, constipation, unexplained weight gain, increased sensitivity to cold, joint pain or stiffness, and muscle weakness. If you have symptoms of hypothyroidism, the most effective way to control them is to take a hormone replacement. That typically involves daily use of a synthetic thyroid hormone called levothyroxine that you take as an oral medication. It is identical to thyroxine, the natural version of a hormone made by your thyroid gland. The medication restores your hormone levels to normal and eliminates hypothyroidism symptoms. You may hear about products that contain a form of thyroid hormones derived from animals. They often are marketed as being natural. Because they are from animals, however, they aren't natural to the human body, and they potentially can cause health problems. The American Thyroid Association's hypothyroidism guidelines recommend against using these products as a first-line treatment for hypothyroidism. Although hormone replacement therapy is effective at controlling symptoms of Hashimoto's thyroiditis, it is not a cure. You need to keep taking the medication to keep symptoms at bay. Treatment is usually lifelong. To make sure you get the right amount of hormone replacement for your body, you must have your hormone levels checked with a blood test once or twice a year. If symptoms linger despite hormone replacement therapy, you may need to have the dose of medication you take each day adjusted. If symptoms persist despite evidence of adequate hormone replacement therapy, it's possible those symptoms could be a result of something other than Hashimoto's thyroiditis. Talk to your health care provider about any bothersome symptoms you have while taking hormone replacement therapy. Victor J. Bernet, MD, is Chair of the Endocrinology Division at the Mayo Clinic in Jacksonville, Florida and is an Associate Professor in the Mayo Clinic College of Medicine. Dr. Bernet served 21+ years in the Army Medical Corps retiring as a Colonel. He served as Consultant in Endocrinology to the Army Surgeon General, Program Director for the National Capitol Consortium Endocrinology Fellowship and as an Associate Professor of Medicine at the Uniformed Services University of Health Sciences. Dr. Bernet has received numerous military awards, was awarded the "A" Proficiency Designator for professional excellence by the Army Surgeon General and the Peter Forsham Award for Academic Excellence by the Tri-Service Endocrine Society. Dr. Bernet graduated from the Virginia Military Institute and the University of Virginia School of Medicine. Dr. Bernet completed residency at Tripler Army Medical Center and his endocrinology fellowship at Walter Reed Army Medical Center. Dr. Bernet's research interests include: improved diagnostics for thyroid cancer, thyroidectomy related hypocalcemia, thyroid hormone content within supplements as well as management of patient's with thyroid cancer. He is the current Secretary and CEO of the American Thyroid Association.

In this episode Dr. Bernet describes that Hashimoto's thyroiditis is an autoimmune condition that usually progresses slowly and often leads to low thyroid hormone levels — a condition called hypothyroidism. The best therapy for Hashimoto's thyroiditis is to normalize thyroid hormone levels with medication. A balanced diet and other healthy lifestyle choices may help when you have Hashimoto's, but a specific diet alone is unlikely to reverse the changes caused by the disease. Hashimoto's thyroiditis develops when your body's immune system mistakenly attacks your thyroid. It's not clear why this happens. Some research seems to indicate that a virus or bacterium might trigger the immune response. It's possible that a genetic predisposition also may be involved in the development of this autoimmune disorder. A chronic condition that develops over time, Hashimoto's thyroiditis damages the thyroid and eventually can cause hypothyroidism. That means your thyroid no longer produces enough of the hormones it usually makes. If that happens, it can lead to symptoms such as fatigue, sluggishness, constipation, unexplained weight gain, increased sensitivity to cold, joint pain or stiffness, and muscle weakness. If you have symptoms of hypothyroidism, the most effective way to control them is to take a hormone replacement. That typically involves daily use of a synthetic thyroid hormone called levothyroxine that you take as an oral medication. It is identical to thyroxine, the natural version of a hormone made by your thyroid gland. The medication restores your hormone levels to normal and eliminates hypothyroidism symptoms. You may hear about products that contain a form of thyroid hormones derived from animals. They often are marketed as being natural. Because they are from animals, however, they aren't natural to the human body, and they potentially can cause health problems. The American Thyroid Association's hypothyroidism guidelines recommend against using these products as a first-line treatment for hypothyroidism. Although hormone replacement therapy is effective at controlling symptoms of Hashimoto's thyroiditis, it is not a cure. You need to keep taking the medication to keep symptoms at bay. Treatment is usually lifelong. To make sure you get the right amount of hormone replacement for your body, you must have your hormone levels checked with a blood test once or twice a year. If symptoms linger despite hormone replacement therapy, you may need to have the dose of medication you take each day adjusted. If symptoms persist despite evidence of adequate hormone replacement therapy, it's possible those symptoms could be a result of something other than Hashimoto's thyroiditis. Talk to your health care provider about any bothersome symptoms you have while taking hormone replacement therapy. Victor J. Bernet, MD, is Chair of the Endocrinology Division at the Mayo Clinic in Jacksonville, Florida and is an Associate Professor in the Mayo Clinic College of Medicine. Dr. Bernet served 21+ years in the Army Medical Corps retiring as a Colonel. He served as Consultant in Endocrinology to the Army Surgeon General, Program Director for the National Capitol Consortium Endocrinology Fellowship and as an Associate Professor of Medicine at the Uniformed Services University of Health Sciences. Dr. Bernet has received numerous military awards, was awarded the "A" Proficiency Designator for professional excellence by the Army Surgeon General and the Peter Forsham Award for Academic Excellence by the Tri-Service Endocrine Society. Dr. Bernet graduated from the Virginia Military Institute and the University of Virginia School of Medicine. Dr. Bernet completed residency at Tripler Army Medical Center and his endocrinology fellowship at Walter Reed Army Medical Center. Dr. Bernet's research interests include: improved diagnostics for thyroid cancer, thyroidectomy related hypocalcemia, thyroid hormone content within supplements as well as management of patient's with thyroid cancer. He is the current Secretary and CEO of the American Thyroid Association.

This episode is a thorough presentation of Graves' Disease from Kimberly Dorris, an educator and expert, and also a patient. In this episode, listeners will gain a thorough understanding of a disease that is often confused with other diagnosis. Kimberly Dorris is the Executive Director and CEO of the Graves' Disease and Thyroid Foundation, a small nonprofit organization based in Rancho Santa Fe, CA. She began working with the GDATF as a volunteer in 2010, and took over day-to-day management of the Foundation in 2011. ​Her responsibilities include organizing patient education events in various locations throughout the U.S.A., managing the Foundation's social media sites, producing print and electronic communications, seeking grant funding, and providing support for patients via phone, e-mail, and an online support forum. ​ ​She also leads a monthly patient support group meeting in Phoenix, AZ. ​Ms. Dorris has a unique perspective on thyroid dysfunction, having lived with both hyperthyroidism and hypothyroidism. She was diagnosed with Graves' disease in 2007 and took methimazole for seven years. ​A​pproximately 18 months after stopping the methimazole, she became hypothyroid and is currently taking replacement hormone. ​ Ms. Dorris received a B.A. from the University of Arizona in 1990 and an M.B.A. from Belmont University in Nashville in 1990. ​P​rior to joining the GDATF, she spent ​8 years with Mercury Nashville Records, a year with KPMG Consulting, and ​ 10 years with a community bank, including a two-year term as chairman of the company's Charitable Giving Committee. NOTES & RESOURCES: GDATFWebsite: http://gdatf.org/ GDATF Online Support Forum: http://gdatf.org/forum/ Reading List: http://gdatf.org/about/about-graves-disease/reading-list-for-patients/ Recommended Links: http://gdatf.org/about/about-graves-disease/links/ GDATF YouTube Site (includes free videos on Graves' disease, autoimmunity, and thyroid eye disease): https://www.youtube.com/user/GravesAndThyroid Facebook: https://www.facebook.com/gdatf Twitter: @GDATF Patients and family members can also e-mail the Graves' Disease Foundation at [email protected] or call toll-free 877-643-3123.

En este episodio explora los siguientes temas: Opciones de tratamiento para la enfermedad de Graves. Opciones de tratamiento para el hipertiroidismo. Peligros de la medicación del hyperthyroidism. Síntomas del hipertiroidismo. Dr. Alejandro Ayala obtuvo su doctorado de la Universidad Federal Fluminense en Río de Janeiro, Brasil, en 1992, y completó su residencia en medicina interna en la Universidad Federal de Sao Paulo. Posteriormente se unió al Programa de Medicina Interna de la Universidad de Georgetown en el Centro Hospitalario de Washington, donde recibió el Premio Saul Zukerman, MD, Humanitarianism in Medicine. El Dr. Ayala obtuvo su formación clínica en Endocrinología en el Hospital Universitario Johns Hopkins, seguido de una beca de investigación en los Institutos Nacionales de Salud (NIH) en Bethesda, Maryland, donde continuó durante los siguientes cinco años como clínico del personal, investigador clínico y facultad de El programa de entrenamiento de endocrinología NIH. Durante este tiempo, los intereses de investigación del Dr. Ayala están relacionados con los trastornos de la Neruendocrinología, la pituitaria y la adrenal. Sus intereses de investigación incluyen hiperaldosteronismo, síndrome de Cushing y feocromocitoma, áreas en las que ha sido autor de más de dos docenas de artículos revisados ​​por pares y ha escrito varios capítulos de libros. NOTAS: The Hormone Foundation Dr. Alejandro Ayala GDATFWebsite: http://gdatf.org/ GDATF Online Support Forum: http://gdatf.org/forum/ Reading List: http://gdatf.org/about/about-graves-disease/reading-list-for-patients/ Recommended Links: http://gdatf.org/about/about-graves-disease/links/ GDATF YouTube Site (includes free videos on Graves' disease, autoimmunity, and thyroid eye disease): https://www.youtube.com/user/GravesAndThyroid Facebook: https://www.facebook.com/gdatf Twitter: @GDATF

In this interview, Dr. Hennessey describes the history, refinements, implementation, physiology, and clinical outcomes achieved over the past several centuries of thyroid hormone replacement strategies. Topics discussed in this episode include: The history of levothyroxin Chinese using thyroid hormone to treat cretinism in the 6th century What is cretinism? Dangers of hypothyroidism during pregnancy Prescribed 3-step process when hypothyroidism is treated when pregnant The history of sheep thyroid as a treatment? In the 1920's thyroid hormone was synthesized T3 was synthesized in the 1950's When to take thyroid medication, morning or night? A rich history of physician intervention in thyroid dysfunction was identified dating back more than 2 millennia. Although not precisely documented, thyroid ingestion from animal sources had been used for centuries but was finally scientifically described and documented in Europe over 130 years ago. Since the reports by Bettencourt and Murray, there has been a continuous documentation of outcomes, refinement of hormone preparation production, and updating of recommendations for the most effective and safe use of these hormones for relieving the symptoms of hypothyroidism. As the thyroid extract preparations contain both levothyroxine (LT4) and liothyronine (LT3), current guidelines do not endorse their use as controlled studies do not clearly document enhanced objective outcomes compared with LT4 monotherapy. Among current issues cited, the optimum ratio of LT4 to LT3 has yet to be determined, and the U.S. Food and Drug Administration (FDA) does not appear to be monitoring the thyroid hormone ratios or content in extract preparations on the market. Taken together, these limitations are important detriments to the use of thyroid extract products. James V. Hennessey, MD is Director of Clinical Endocrinology at Beth Israel Deaconess Medical Center in Boston, MA. He is an Associate Professor of Medicine at the Harvard medical School. He completed medical training at the Medical Faculty of the Karl Franzens University in Graz Austria. He served as an Intern and Medical Resident at the New Britain Hospital in Connecticut. He entered active duty with the USAF Medical Corps as an Internist/Flight Surgeon after residency and later completed subspecialty training in endocrinology and metabolism at the Walter Reed Army Medical Center in Washington DC where he conducted research in thyroxine bioequivalence. Following fellowship Dr. Hennessey served as the Chief of Endocrinology at USAF Medical Center Wright-Patterson in Ohio and later joined the faculty at Wright State University School of Medicine as the Director of Clinical Clerkships. Top 10 most prescribes drugs in the U.S. (monthly) - Monthly prescriptions, nearly 22 million

¿Cómo sabemos si usted tiene hipotiroidismo? ¿Qué significa si es difícil concentrarse o enfocar la mente? ¿Qué significa si usted tiene altos niveles de TSH? ¿Cómo se diagnostica el hipotiroidismo? ¿Qué es Hashimotos? ¿Cuál es el tratamiento para el hipotiroidismo? ¿Puede la dieta ayudar con el hipotiroidismo? ¿Cuándo es el mejor momento del día para tomar su medicina de hipotiroidismo? ¿Dónde puede encontrar un médico para tratar el hipotiroidismo? Dra. Sandra Daniela Licht de Hospital General de consultorio particular y en INEBA ( Instituto de Neurociencias de Buenos Aires) Endocrinologia ESPECIALIDAD Establecimiento: General de Agudos J. M. Ramos Mejía. Título: Clinica Medica. Establecimiento: Hospital General de Agudos Carlos G. Durand. Titulo: Endocrinologia ACTIVIDAD ACADEMICA Y DOCENTE Instructora de Residentes de Endocrinología, Htal Durand (1993-1995) Docente de la Diplomatura en Enfermedades Tiroideas de la Facultad de Medicina de la Universidad Nacional de Tucumán SOCIEDADES CIENTIFICAS • Miembro Titular, Sociedad Argentina de Endocrinología y Metabolismo. • Miembro Titular, Sociedad Latinoamericana de Tiroides. • Miembro Titular, The Endocrine Society. • Miembro Titular, American Thyroid Asociation. • Miembro del Comité de Asuntos Internacionales, The Endocrine Society (2005-2006). • Miembro del Comité Hormone Foundation, The Endocrine Society (2007-2010). • Miembro del Comité Patient Education and Advocacy Committee, American Thyroid Association (2008). • Miembro del Comité Clinical Affaires, American Thyroid Association. • Miembro del Comité Working Group on Disparities in Clinical Trials, The Endocrine Society. • Miembro del Comité de Publicaciones, The Endocrine Society. • Miembro del Comité Clinical Guidelines, The Endocrine Society. • Asesora médica de ACTIRA. • Asociación de Pacientes con Cáncer de Tiroides de la República Argentina. • Miembro del Medical Advisory Panel of Thyroid Cancer Alliance (desde el año 2011). Asociación Americana de la Tiroides - Español

In this episode, we hear from Judy O'Reilly. Judy was diagnosed with thyroid cancer in 2011. Following surgery, Judy speaks about the frequent challenges, including adjusting medication dosages, hypothyroidism, and her energy levels hitting the wall during daily activities. For Judy, the cancer diagnosis forced the conversation of talking about death with her children and husband. A singer and musician, the thyroid cancer and resulting surgery has caused vocal challenges. In this episode, we hear from Judy O'Reilly. Judy was diagnosed with thyroid cancer in 2011. Following surgery, Judy speaks about the frequent challenges, including adjusting medication dosages, hypothyroidism, and her energy levels hitting the wall during daily activities. For Judy, the cancer diagnosis forced the conversation of talking about death with her children and husband. A singer and musician, the thyroid cancer and resulting surgery has caused vocal challenges. She is the founder and former facilitator of THYCA Atlanta. Prior to starting the once/month support group held at Emory University's Winship Cancer Institute, Judy O'Reilly offered email and phone support. Judy began her involvement/volunteering with THYCA one year after diagnosis/surgery/RAI. Prior to thyroid cancer, Judy O'Reilly had been a music educator and an entertainer. She was the female vocalist for the Atlanta Blue Notes Big Band, as well as their Combo. As a solo performer (piano/vocals), Judy specialized in senior care facilities offering up an extensive selection of the great American songbook. Ms. O'Reilly resigned/retired from performing soon after a second surgery - a completion of a previous partial thyroidectomy - due to complications. In 2015 Judy began a return to entertaining as a volunteer in the grand piano lobby of the Winship Cancer Institute, Atlanta.

En este episodio, estamos con la Dra. Alicia Gauna, Jefa División Endocrinología del Hospital Ramos Mejía, Buenos Aires. Ella es Coordinadora del Comité de Recertificación de Endocrinología y Metabolismo (CREM), Directora de Beca de Dra. Florencia Rodriguez, Ministerio de Salud Pública, 2012-2013, Integrante del Comité Científico del XV Congreso Latinoamericano de Tiroides. Brasil, 2013. En esta entrevista, Dra Gauna comparte información clave sobre hipotiroidismo y cáncer de tiroides. Los temas incluyen: Síntomas del hipotiroidismo Síntomas de hipotiroidismo en la salud mental Diagnóstico del hipotiroidismo Menopausia e hipotiroidismo Embarazo e hipotiroidismo Cáncer de tiroides e hipotiroidismo Notas: YouTube con Dra. Gauna https://www.youtube.com/watch?v=Nb-o5RVszaY http://www.revistaohlala.com/1452915-que-sabes-de-tiroides

Dr. Schneider specializes in endocrine surgery, treating diseases of the thyroid, parathyroid, and adrenal glands. He utilizes several minimally invasive techniques to treat endocrine disorders (endoscopic thyroidectomy, minimally invasive parathyroidectomy, laparoscopic adrenalectomy, focused exploration for recurrent thyroid cancer). This episode explores the following topics: Treatment options for Graves' disease. Treatment options for hyperthyroidism. Dangers of hyperthyroidism medication. Symptoms of hyperthyroidism. Why smokers are a higher risk in the treatment of hyperthyroidism. NOTES: Dr. David Schneider http://www.uwhealth.org/findadoctor/profile/david-f-schneider-md-ms/8885

El Dr Fabián Pitoia es Médico Endocrinólogo, es Jefe de la Sección Tiroides y Coordinador del Área Investigación de la División Endocrinología del Hospital de Clínicas - Universidad de Buenos Aires, es Docente adscripto de la Facultad de Medicina - Jefe de Trabajos prácticos de Medicina B (Facultad de Medicina - UBA) y Docente de la Carrera de Especialistas en Endocrinología y Metabolismo de la UBA. Especialidad recertificada en Diciembre de 2013. El Dr Pitoia tiene más de 200 publicaciones de sus investigaciones, más de 50 listadas en Pubmed, ha sido primer autor de las Guías Latinoamericanas para el diagnóstico y tratamiento del cáncer de tiroides, también el primer autor de las Guías Intersocietarias Argentinas para manejo de pacientes con cáncer de tiroides 2014. En esta entrevista, discutiremos: Los síntomas que una experiencia del paciente puede saber que tienen un problema Si cirugía siempre es una necesidad Cuándo se quita sólo la mitad de la tiroides? Cómo ayuda la patología en el diagnóstico? Cuál es la mejor manera de encontrar un buen cirujano? Los análisis de sangre relacionados con los pacientes con tiroides? Notes: https://www.facebook.com/Dr.Pitoia/ https://twitter.com/fabian_pitoia www.glandulatiroides.com.ar Www.cancerdetiroides.com.ar

Dr. Babak Larian is a highly experienced, board certified Ear, Nose, & Throat Specialist and Head & Neck surgeon. Dr. Larian is the current Clinical Chief of the Division of Otolaryngology at Cedars-Sinai Hospital in Los Angeles. Dr. Larian's Center For Head and Neck Surgery is located in Beverly Hills, California. In this episode, Dr. Larian discusses his experience treating thyroid disorders, including his medical missions to Central America. During this interview, you will hear greater detail about the following topics: The most recent American Thyroid Association's guidelines and updates to treating thyroid cancer compared to past approaches Minimally invasive thyroid surgery, which results in less scarring and less discomfort Breaking away from the old tradition of a large incision Testing for parathyroid imbalance What might it mean when the patient feels anxious, has to urinate during the night, impaired mental function, and calcium imbalance? Which blood test reveals possible parathyroid issues? The common denominator in patients who recover post thyroid cancer surgery A parathyroid trend in women 40 - 60 years old The importance of staying in tune with your body and its signals NOTES: Dr. Babak Larian http://www.larianmd.com/ P: 310.461.0300 American Thyroid Association Guidelines http://www.thyroid.org/professionals/ata-professional-guidelines/

El Dr. Carlos Simon Duque es un especialista en cabeza y cuello de Colombia. En esta entrevista, discutiremos una visión general del cáncer de tiroides, incluyendo las siguientes preguntas: ¿Qué debe saber un paciente antes de la cirugía, qué esperar? Después de la cirugía, un paciente puede sentir síntomas como hipotiroidismo. ¿Cómo lo manejas mejor? ¿Cuáles son algunas de las luchas mas complicados que usted ve con sus pacientes después de la tiroidectomía? ¿Qué pacientes recuperan mejor? ¿Qué puede hacer un paciente para sentirse mejor después de la cirugía? ¿Cuándo es el mejor momento del día para tomar la medicina de la tiroides? Usted ha trabajado tanto en los Estados Unidos como en Colombia, ¿cuáles son algunas de las diferencias en la atención y el tratamiento? ¿Qué has descubierto a lo largo del camino, que le dirías a usted de 30 años de edad si puede? ¿Actualmente está trabajando en algún estudio o investigación?

How well does your body make energy? How does your body repair? How well are your anti-oxidants working? How well do you rid your body of free radicals? Are you pre-conditioned to crisis? The next generation of lab testing and diagnosis has arrived with resources such as Cyrex Labs and Nutreval. Thyroid health issues mimic other ailments, such as inflammation, gluten intolerance, and increased permeability (leaky gut). In this episode, hear from Dr. Engelman, recognized as one of the top doctors in functional integrative medicine, he has advanced degrees and certifications in functional, metabolic, anti-aging and stem cell medicine. Engelman Health Institute is advanced science, and personalized care. This "new medicine" incorporates the best of traditional practices and natural and alternative diagnostic modalities. http://www.engelmanhealth.com/ https://www.gdx.net/product/nutreval-fmv-nutritional-test-blood-urine https://www.cyrexlabs.com/

Karen Smyers has competed as a professional triathlete for 30 years. In her lengthy career, she has won seven National and four World Championship titles, including a dramatic come-from-behind victory in the Hawaiian Ironman World Championships in 1995. Her victory at the short-course ITU Triathlon World Championship just 5 weeks later still earns her the distinction of being the only woman ever to win triathlon's two most prestigious races in the same year. In this episode, we hear Karen describe what the calls, 'character building' moments, including how she approached thyroid cancer in the midst of of preparing for the 2000 Olympics. Other obstacles included a torn hamstring, being hit by a 18-wheeler, and a broken collar bone. Regardless of the obstacle, Karen was able to stay focused on and win the Pro National Ironman Championship. At 42 and post thyroid cancer, Karen gave birth to her second child. Listen to this episode and you will be inspired by Karen's determination, perseverance, and approach to living life to the fullest. And, in some cases pushing boundaries and achieving what some would say not possible. Currently, Karen shares her experience, optimism, and passion for racing as a coach, motivational speaker and co-director of the Lincoln Kids Triathlon. She is a 1983 graduate of Princeton University and lives in Lincoln, MA with daughter Jenna, son Casey, and husband and frequent training partner Michael King. Contact: 11 Giles Rd, Lincoln, MA 01773 [email protected] www.karensmyers.com

This interview is a part of the lifestyle stories featured on the Doctor Thyroid podcast, an opportunity to hear from athletes and overachievers, and how they approach their diagnosis, surgery, and recovery. In this case, we hear from Evan Simon, Head Strength and Conditioning Coach at Oregon State University. Evan was diagnosed with advanced Stage IV thyroid cancer, which resulted a 13 hour surgery. At the end of his surgery, Evan was told he would not be able to lift his hands overhead for 3 months, instead he broke the odds, taking him only 3 weeks. Evan shares with us, his approach to first hearing the news, how he chose to share the news with his family, including his two young daughters, and what he did to speed his recovery. Evan will offer you tips to improve better your recovery, including physical rehabilitation and having an optimistic mindset. During the interview, we also hear from special guest, Stasi Kasianchuk, MS, RD, Sports Dietitian at Oregon State University. Staci shares her experience in treating Evan through nutrition as a means to a better recovery, and improved lifestyle post-surgery.

Dr. Jonas de Souza, Assistant Professor of Medicine, specializes in the treatment of head and neck cancer, including thyroid cancer at the University of Chicago. Talking points of this episode: Financial toxicity What is the COST tool? Patient-Centered Outcomes Research? When is the best time to discuss costs with the thyroid cancer patient? Who is most at risk of the increased financial burden of thyroid cancer? How can a patient best prepare for the costs of thyroid cancer? Resources: The COST tool for measuring the financial costs of thyroid cancer, http://www.facit.org/FACITOrg/Questionnaires

Hear about the advances in thyroid ultra sound technology, along with the patient process from diagnosis to surgery. Key topics in this episode include how to research a surgeon, requesting a second opinion, selecting the best hospital, and the challenges faced when operating on the neck. This episode features Dr. Joseph Sniezek, who is the Medical Director of Head & Neck Endocrine Surgery for Swedish Health Services. Too often, the time between being told by your doctor to get an ultrasound to biopsy, often results in anxiety and a disconnect between surgeon - radiologist - pathologist. Now, with better technology, especially in the area of ultra sound, the multiple trips to specialists can be eliminated.

This episode features Dr. Shawn Soszka. Topics covered in today's interview include, starting your day right, tendon issues due to thyroid disease, insomnia, dizziness, painful feet, temperature testing, hypothyroidism, low dose Naltrexone, selenomethionine, and why some people feel worse when exercising. Also, discussed is adrenal function and optimal time of day for body temperature testing as related to the thyroid disease. Dr. Soszka strives to integrate both systems of medicine. a focus on functional medicine, with emphasis on treating gastrointestinal, chronic disease, and endocrine based conditions. He specializes in: fatigue/adrenal exhaustion, thyroid disorders, digestion/gut health, autoimmune diseases.

In this episode hear from Dr. Greg Nigh, a Naturopath in Portland, OR. Dr. Nigh will discuss the following topics: Dangers of garlic and soy Overcoming sugar cravings Hashimotos and hypothyroidism Specialty laboratories The dangers of using TSH as the sole yardstick